thirteen shrs were divided into 2 groups : 0.1 ml of sesame oil was administered to one group ( the spironolactone-lactone-untreated group , n = 6 ) and 20 mg of spironolactone in 0.1 ml of sesame oil was administered to the other group ( the spironolactone-treated group , n = 7 ) by the subcutaneous route for 10 days in succession .
C0022947
lactone
C0037982
spironolactone